Aytu BioScience (AYTU) Misses Q2 EPS by 105c
Tweet
Share
E-mailGet Alerts AYTU Hot Sheet
Join SI Premium – FREE
Aytu BioScience (NASDAQ: AYTU) reported Q2 EPS of ($1.05), $1.05 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $15.2 million.
For earnings history and earnings-related data on Aytu BioScience (AYTU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Microsoft plans data center push to triple its computing power - Bloomberg
- Zumiez, Inc. (ZUMZ) Misses Q2 EPS by 6c, Misses on Revenue; Offers Q3 Guidance
- Laser Photonics prices $7.9M public offering at $0.75 per share
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
